This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
The authors stated that, for most data, the same sources as those cited by the ACS were used. These sources covered about 7,000 patients undergoing EDT. However, no information on the primary studies was given. Mortality in the general population came from statistics from the general US population. Some assumptions were also made.
Methods used to judge relevance and validity, and for extracting data
The primary studies might have been identified selectively from amongst those available in the literature. There were no details of the methods used to combine the original studies.
Measure of benefits used in the economic analysis
The summary benefit measure used was the quality-adjusted life-years (QALYs). These were estimated using a modelling approach. The utility weights were derived from the literature. Limited information on the sources of these data and the methods used to derive them was given. The QALYs included the utilities of both victims and providers. The authors stated that utility weights for impaired survivors of EDT are difficult to obtain and the data had to be taken from cardiac arrest or stroke survivors. It was assumed that intact survivors have the same quality of life as the general population. The benefits were discounted at an annual rate of 3%.
Direct costs
The perspective adopted in the costs analysis was unclear, although the authors stated that societal costs were considered. The cost categories considered were thoracotomy and other procedures, hospital stay, long-term care, and care associated with provider exposure. The costs used in the model took the status of the patient (intact or neurologically impaired) into account. A detailed breakdown of the cost items was not given and the costs were presented as macro-categories. The unit costs and the quantities of resources used were not presented separately. Most of the costs were derived from the National Inpatient Sample (NIS) from the Health Care Utilization Project database. Hospital charges were adjusted by cost-to-charge ratio. The costs associated with provider exposure were derived from a published economic analysis. Discounting was relevant and was carried out at an annual rate of 3%. The price year was not reported.
Statistical analysis of costs
The costs were treated deterministically in the base-case, but probabilistic distributions were assigned to costs in the sensitivity analysis.
Indirect Costs
Productivity costs were not considered.
Currency

US dollars ($).
Sensitivity analysis
A deterministic sensitivity analysis was carried out on many model inputs to evaluate the robustness of the costeffectiveness results. Alternative ranges of estimates were taken from published studies. A probabilistic sensitivity analysis was also undertaken using a Monte Carlo simulation. The probabilistic distributions given to the model inputs were presented.
Estimated benefits used in the economic analysis
The expected QALYs were not reported.
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Cost results
The total costs were not reported.
Synthesis of costs and benefits
Incremental cost-utility ratios were calculated to combine the costs and benefits of the alternative strategies.
For penetrating trauma, the incremental cost per QALY gained with EDT over no thoracotomy was $16,125 at an average survival probability of 0.10. The probabilistic sensitivity analysis indicated that the probability that the cost per QALY was below the threshold of $50,000 was 93.4%.
For blunt trauma, the incremental cost per QALY gained with EDT over no thoracotomy was $163,136 at an average survival probability of 1.6 per 100. The probabilistic sensitivity analysis showed that the probability that the cost per QALY was below the threshold of $50,000 was 37%.
The deterministic sensitivity analysis showed that, for the penetrating trauma case, the model was sensitive to survival probability. For example, with a survival probability of 2 in 100, the cost per QALY rose to $ 66,403. The model was insensitive to other inputs. For blunt trauma patients, as the probability of survival after EDT approached zero, the strategy was dominated, meaning that no thoracotomy was more effective and less expensive. With a survival gain as high as 5 in 100, the incremental cost per QALY gained with EDT was $84,137. The impact of occupational exposure did not affect the conclusions of the analysis.
